A new multiple sampling technique for obtaining blood from the portal vein has been used to investigate the effects of neurotensin on insulin and glucose portal blood levels in rats rendered hyperglycemic by a constant glucose infusion. The peptide has been first injected acutely (2 microgram/rat iv), and then constantly infused (0.5 microgram/min for 55 min). The preliminary results indicate that no effect of the acute injection could be observed, but hyperglycemia and hyperinsulinemia were induced by the constant infusion of the peptide. It is suggested that neurotensin may stimulate the release of insulin probably through a direct mechanism
It has been reported that substance P influences plasma glucagon concentrations; some investigators ...
It has been reported that substance P influences plasma glucagon concentrations; some investigators ...
The [14C]2-deoxyglucose method was applied to measure the effects of the injection of neurotensin (7...
An immune neutralization in vivo model, using antiglucagon immunoglobulins, was characterized and fo...
The effects of synthetic neurotensin and xenopsin on plasma glucagon and insulin secretion were inve...
The effects of synthetic neurotensin and xenopsin on plasma glucagon and insulin secretion were inve...
The effects of synthetic neurotensin and xenopsin on plasma glucagon and insulin secretion were inve...
Effects of synthetic neurotensin on the endocrine pancreas were studied in nine normal and six hypop...
Recent clinical studies demonstrated that transient postprandial hyperglycemia and hyperinsulinemia ...
Recent clinical studies demonstrated that transient postprandial hyperglycemia and hyperinsulinemia ...
Recent clinical studies demonstrated that transient postprandial hyperglycemia and hyperinsulinemia ...
The pharmacological roles of the neuropeptide neurotensin through its three known receptors are vari...
International audienceThe pharmacological roles of the neuropeptide neurotensin through its three kn...
A rodent model of controlled acute hyperglycemia that is sen-sitive to glucose-lowering agents insul...
It has been reported that substance P influences plasma glucagon concentrations; some investigators ...
It has been reported that substance P influences plasma glucagon concentrations; some investigators ...
It has been reported that substance P influences plasma glucagon concentrations; some investigators ...
The [14C]2-deoxyglucose method was applied to measure the effects of the injection of neurotensin (7...
An immune neutralization in vivo model, using antiglucagon immunoglobulins, was characterized and fo...
The effects of synthetic neurotensin and xenopsin on plasma glucagon and insulin secretion were inve...
The effects of synthetic neurotensin and xenopsin on plasma glucagon and insulin secretion were inve...
The effects of synthetic neurotensin and xenopsin on plasma glucagon and insulin secretion were inve...
Effects of synthetic neurotensin on the endocrine pancreas were studied in nine normal and six hypop...
Recent clinical studies demonstrated that transient postprandial hyperglycemia and hyperinsulinemia ...
Recent clinical studies demonstrated that transient postprandial hyperglycemia and hyperinsulinemia ...
Recent clinical studies demonstrated that transient postprandial hyperglycemia and hyperinsulinemia ...
The pharmacological roles of the neuropeptide neurotensin through its three known receptors are vari...
International audienceThe pharmacological roles of the neuropeptide neurotensin through its three kn...
A rodent model of controlled acute hyperglycemia that is sen-sitive to glucose-lowering agents insul...
It has been reported that substance P influences plasma glucagon concentrations; some investigators ...
It has been reported that substance P influences plasma glucagon concentrations; some investigators ...
It has been reported that substance P influences plasma glucagon concentrations; some investigators ...
The [14C]2-deoxyglucose method was applied to measure the effects of the injection of neurotensin (7...